https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
The efficacy of the intervention was evaluated at three time points (baseline, posttest, and 3-month follow-up). Our results indicated that all AD patients do not benefit to the same extent from the training. Two variables appeared to influence the likelihood that participants increase and maintain their reliance on the fluency cues after the intervention the ability to detect the fluency manipulation and the preservation of implicit metacognitive skills. These findings indicate the importance of metacognition for infe